Evidence map›Paper›PMID 25137235›Full record

ArticlePloS one2014

Effect of dialysis initiation timing on clinical outcomes: a propensity-matched analysis of a prospective cohort study in Korea.

Jeonghwan Lee, Jung Nam An, Jin Ho Hwang, Yong-Lim Kim, Shin-Wook Kang, Chul Woo Yang, Nam-Ho Kim, Yun Kyu Oh, Chun Soo Lim, Yon Su Kim and 1 more

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Should we abandon GFR in the decision to initiate chronic dialysis?Pediatric nephrology (Berlin, Germany) · 2020
    Review
  5. Survival in children requiring chronic renal replacement therapy.Pediatric nephrology (Berlin, Germany) · 2018
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jeonghwan LeeDepartment of Internal Medicine, Hallym University Hangang Sacred Heart Hospital, Seoul, Korea; Clinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea.
Jung Nam AnDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
Jin Ho HwangDepartment of Internal Medicine, Chung-Ang University Medical Center, Seoul, Korea.
Yong-Lim KimClinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea; Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Shin-Wook KangClinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Chul Woo YangClinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea; Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
Nam-Ho KimClinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Yun Kyu OhClinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
Chun Soo LimClinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
Yon Su KimClinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Jung Pyo LeeClinical Research Center for End Stage Renal Disease (CRC for ESRD), Daegu, Korea; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundControversy persists regarding the appropriate initiation timing of renal replacement therapy for patients with end-stage renal disease. We evaluated the effect of dialysis initiation timing on clinical outcomes. Initiation times were classified according to glomerular filtration rate (GFR).

methodsWe enrolled a total of 1691 adult patients who started dialysis between August 2008 and March 2013 in a multi-center, prospective cohort study at the Clinical Research Center for End Stage Renal Disease in the Republic of Korea. The patients were classified into the early-start group or the late-start group according to the mean estimated GFR value, which was 7.37 ml/min/1.73 m2. The primary outcome was patient survival, and the secondary outcomes were hospitalization, cardiovascular events, vascular access complications, change of dialysis modality, and peritonitis. The two groups were compared before and after matching with propensity scores.

resultsBefore propensity score matching, the early-start group had a poor survival rate (P<0.001). Hospitalization, cardiovascular events, vascular access complications, changes in dialysis modality, and peritonitis were not different between the groups. A total of 854 patients (427 in each group) were selected by propensity score matching. After matching, neither patient survival nor any of the other outcomes differed between groups.

conclusionsThere was no clinical benefit after adjustment by propensity scores comparing early versus late initiation of dialysis.

Indexed as

Cardiovascular DiseasesFemaleGlomerular Filtration RateHospitalizationHumansKidney Failure, ChronicMaleMiddle AgedPeritonitisPropensity ScoreProspective StudiesRenal DialysisRenal Replacement TherapyRepublic of KoreaSurvival RateTime Factors

Identifiers

PMID25137235
PMCPMC4138196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.